CSF Catecholamine Profile in Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Patients experiencing apoplectic intracranial processes may develop neurogenic cardiomyopathy (NC). The purpose of this research is to determine whether cerebrospinal fluid (CSF) catecholamine levels are elevated in subarachnoid hemorrhage (SAH) patients with NC when compared to those without NC.
Observational study of consecutive grades 3–5 SAH patients requiring ventriculostomy. All patients underwent CSF sampling for catecholamine levels, and transthoracic echocardiography (TTE) to assess for NC, within 48 h of SAH onset. Univariate analyses were performed to identify clinical and laboratory variables associated with NC. Clinical variables associated with NC in the univaritate analysis were entered into logistic regression models along with the candidate catecholamine variables to identify predictors of NC.
The study group contained 100 patients—mean age of study subjects was 58 years, 73% were female, and 15% developed NC. NC patients were more likely to have a worse clinical grade than patients without NC (80 vs. 34%, P = 0.001). NC patients possessed greater DOPA levels (5.83 vs. 4.60 nmol/l, P = 0.044), and a trend toward greater noradrenergic activity as determined by NE/DHPG ratio (0.3799 vs. 0.2519, P = 0.073). Multivariate analysis identified worse clinical grade (OR 7.09, P = 0.005) and possibly NE levels (OR 1.005, P = 0.057) as independent predictors of NC. Bivariate analysis reinforced the findings for NE (OR 1.006, P = 0.022), and also identified DOPA levels (OR 1.001, P = 0.034) and NE/DHPG (OR 22.18, P = 0.019) as predictors of NC.
SAH patients with NC tend to have greater CSF catecholamine levels than those without NC. However, the development of NC may also be related to factors not evaluated by our study.
- Bybee K, Kara T, Prasad A, et al. Systematic review: transient left ventricular apical balooning—a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004;141:858–65.
- Lee V, Oh J, Mulvagh S, Wijdicks E. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5:243–9. CrossRef
- Naredi S, Lambert G, Eden E, et al. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke. 2000;31:901–6.
- Kopelnik A, Zaroff J. Neurocardiogenic injury in neurovascular disorders. Crit Care Clin. 2007;22:733–52. CrossRef
- Wittstein I, Thiemann D, Lima J, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539–48. CrossRef
- Banki N, Kopelnik A, Dae M, et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2005;112:3314–9.
- Eisenhofer G, Goldstein D, Stull R, et al. Simultaneous liquid chromatographic determination of 3, 4-dihydroxyphenylglycol, catecholamines, and 3, 4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem. 1986;32:2030–3.
- Khush K, Kopelnik A, Tung P, et al. Age and aneurysm position predict patterns of left ventricular dysfunction after subarachnoid hemorrhage. J Am Soc Echocardiogr. 2005;18:168–74. CrossRef
- Banki N, Kopelnik A, Tung P, et al. Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg. 2006;105:15–20. CrossRef
- Kramer A, Hehir M, Nathan B, et al. A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage. J Neurosurg. 2008;109:199–207. CrossRef
- Kothavale A, Banki N, Kopelnik A, et al. Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care. 2006;4:199–205. CrossRef
- Tung P, Kopelnik A, Banki N, et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004;35:548–53. CrossRef
- Ueyama T, Kaamatsu K, Hano T, Yamamoto K, Tsuruo Y, Nishio I. Emotional stress induces transient left ventricular hypocontraction in the rat via activation of cardiac adrenoceptors. Circ J. 2002;66:712–3. CrossRef
- Eisenhofer G, Kopin I, Goldstein D. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev. 2004;56:331–49. CrossRef
- Feenstra M. Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward. Prog Brain Res. 2000;126:133–63. CrossRef
- Raskind M, Peskind E, Holmes C, Goldstein D. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer’s disease. Biol Psychiatry. 1999;46:756–65. CrossRef
- Ebinger G. The significance of homovanillic acid and 3, 4-dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid. J Neurochem. 1987;48:1725–9. CrossRef
- Goldstein D, Holmes C, Axelrod F. Plasma catechols in familial dysautonomia—a long-term follow-up study. Neurochem Res. 2008;33:1889–93. CrossRef
- Lenders J, Willemsen J, Beissel T, Kloppenborg P, Thien T, Benraad T. Value of the plasma norepinephrine/3, 4-dihydroxyphenylglycol ratio for the diagnosis of pheochromocytoma. Am J Med. 1992;92:147–52. CrossRef
- Atuk N, Hanks J, Weltman J, Bogdonoff D, Boyd D, Vance M. Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma. J Clin Endocrinol Metab. 1994;79:1609–14. CrossRef
- Howes L, Hawksby C, Reid J. Comparison of plasma 3, 4-dihydroxyphenylethylene glycol and norepinephrine levels as indices of sympathetic activity in man. Eur J Invest. 1986;16:18–21. CrossRef
- Du X, Esler M, Dart A. Sympatholytic action of intravenous amiodarone in the rat heart. Circulation. 1995;91:462–70.
- Lambert G, Naredi S, Eden E, Rydenhag B, Friberg P. Monoamine metabolism and sympathetic nervous system activation following subarachnoid hemorrhage—influence of gender and hydrocephalus. Brain Res Bull. 2002;58:77–82. CrossRef
- Devinsky O, Emoto S, Goldstein D, et al. Cerebrospinal fluid and serum levels of DOPA, catechols, and monoamine metabolites in patients with epilepsy. Epilepsia. 1992;33:263–70. CrossRef
- Geracioti T, Baker D, Ekhator N, et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry. 2001;158:1227–30. CrossRef
- Post R, Lake C, Jimerson D, et al. Cerebrospinal fluid norepinephrine in affective illness. Am J Psychiatry. 1978;135:907–12.
- Post R, Gordon E, Goodwin F, Bunney W. Central norepinephrine metabolism in affective illness—MHPG in the cerebrospinal fluid. Science. 1973;179:1002–3. CrossRef
- Oehmke M, Podranski T, Mann M, Frickey N, Kuhn D, Hempelmann G. Perioperative concentrations of catecholamines in the cerebrospinal fluid and plasma during spinal anesthesia. Acta Anaesthesiol Scand. 2008;52:487–92. CrossRef
- Nader N, Ignatowski T, Kurek C, Knight P, Spengler R. Clonidine supresses plasma and cerebrospinal fluid concentrations of TNF-alpha during the perioperative period. Anesth Analg. 2001;93:363–9.
- Masuda T, Sato K, Yamamoto S, et al. Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke. 2002;33:1671–6. CrossRef
- Espiner E, Leikis R, Ferch R, et al. The neuro-cardio-endocrine response to acute subarachnoid hemorrhage. Clin Endocrinol. 2002;56:629–35. CrossRef
- Benarroch E. The locus ceruleus norepinephrine system. Neurology. 2009;73:169–1704.
- Zaroff J, Pawlikowska L, Miss J, et al. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorhage. Stroke. 2006;37:1680–5. CrossRef
- CSF Catecholamine Profile in Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy
Volume 14, Issue 3 , pp 401-406
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press Inc
- Additional Links
- Subarachnoid hemorrhage
- Sympathetic nervous system
- Neurogenic cardiomyopathy
- Cerebrospinal fluid
- Industry Sectors
- Author Affiliations
- 1. Cerebrovascular and Neurocritical Care Division, Thomas Jefferson Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA, 19107, USA
- 2. Section on Medical Neuroendocrinology, Reproductive and Adult Endocrinology Program, National Institutes of Health, Bethesda, MD, USA
- 3. Department of Neurology, Thomas Jefferson Medical Center, Philadelphia, PA, USA
- 4. Department of Medicine, Thomas Jefferson Medical Center, Philadelphia, PA, USA